Social Support, Insomnia, and Adherence to Cognitive Behavioral Therapy for Insomnia After Cancer Treatment

Abstract

Objective/Background While cognitive-behavioral therapy for insomnia (CBT-I) has been shown to be efficacious in treating cancer survivors’ insomnia, 30–60% of individuals have difficulty adhering to intervention components. Psychosocial predictors of adherence and response to CBT-I, such as social support, have not been examined in intervention studies for cancer survivors. Participants Datafroma randomized placebo-controlled 2 × 2 trial of CBT-I and armodafinil (a wakefulness promoting agent) were used to assess adherence. Ninety-six cancer survivors participated in the trial (mean age 56, 86% female, 68% breast cancer). Methods CBT-I and armodafinil were administered over the course of seven weeks, and participants were assessed at baseline, during intervention, postintervention, and at a three-month follow-up. Social support was assessed using a Functional Assessment of Chronic Illness Therapy subscale, insomnia severity was assessed using the Insomnia Severity Index, and adherence was measured based on CBT-I sleep prescriptions. Results At baseline, social support was negatively correlated with insomnia severity (r = −0.30, p = 0.002) and associations between social support, CBT-I, and insomnia were maintained through the three-month follow-up. Social support was positively associated with adherence to CBT-I during intervention weeks 3, 4, and 5, and with overall intervention adherence. At postintervention, both social support and treatment with CBT-I independently predicted decreased insomnia severity (p < 0.01) when controlling for baseline insomnia severity. Conclusions Higher social support is associated with better intervention adherence and improved sleep independent of CBT-I. Additional research is needed to determine whether social support can be leveraged to improve adherence and response to CBT-I.

The Psychological Pressures of Breast Cancer Patients During the COVID-19 Outbreak in China—A Comparison With Frontline Female Nurses

“…The ISI (10) is a seven-item instrument for insomnia assessment utilizing a 5-point Likert scale (0-4, not at all to extremely). The insomnia status was divided into no sleep difficulties (0-7), mild (8)(9)(10)(11)(12)(13)(14), moderate (15)(16)(17)(18)(19)(20)(21), and severe insomnia (22)(23)(24)(25)(26)(27)(28). The respondents whose scores were higher than 7 in ISI were thought to have sleep problems.…”

Factors Associated With Healthcare Workers' Insomnia Symptoms and Fatigue in the Fight Against COVID-19, and the Role of Organizational Support

“…For example, it has been documented that high levels of social support attenuate insomnia and fatigue symptoms associated with stress (13)(14)(15). In particular, previous studies have reported that organizational support improves job satisfaction for HCWs with high burnout levels (16).…”

The Impact of the COVID-19 Pandemic on Anxiety and Depression in Breast Cancer Patients in Tunisia

“…The subscales of anxiety and depression were scored separately by summing the items and then classifying as follows: normal (0-7), possible (8)(9)(10) and con rmed (≥ 11) [8]. For a relevant analysis, both scales were splited on moderate (11)(12)(13)(14), severe (15)(16)(17)(18)(19)(20)(21) [8].…”

“…A prospective study with a long-term follow-up for patients showed that family support was associated with both low levels of, and quick improvement from, depression [16]. Kamen et al [17] showed that family support was related to less severe insomnia at baseline in BC patients. Additionally, one previous study demonstrated that family support could avoid or alleviate certain mood di culties in BC patients in the Chinese population [18].…”